Ignite Creation Date:
2025-12-24 @ 2:04 PM
Ignite Modification Date:
2026-01-04 @ 4:39 PM
Study NCT ID:
NCT00816595
Status:
COMPLETED
Last Update Posted:
2017-06-15
First Post:
2008-12-31
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Pentostatin, Cyclophosphamide, and Rituximab With or Without Bevacizumab in Treating Patients With B-Cell Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Sponsor:
Mayo Clinic
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2009-02
Start Date Type:
None
Primary Completion Date:
2013-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-11-29
Completion Date Type:
ACTUAL
First Submit Date:
2008-12-31
First Submit QC Date:
None
Study First Post Date:
2009-01-01
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2014-04-09
Results First Submit QC Date:
None
Results First Post Date:
2014-05-09
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-05-23
Last Update Post Date:
2017-06-15
Last Update Post Date Type:
ACTUAL